De Novo HER2 S310Y mutation associates with poor response to EGFR tyrosine kinase inhibitor in activating EGFR-mutant NSCLC patient: A case report
Gao, Fei, Wu, Xiuyan, Wu, Jie, Li, Yanlin, Miao, Zhibo, Song, LeiVolume:
17
Journal:
European Journal of Inflammation
DOI:
10.1177/2058739219827166
Date:
January, 2019
File:
PDF, 143 KB
2019